14 results
10-K
2023 FY
ADCT
Adc Therapeutics SA
13 Mar 24
Annual report
12:25pm
to ensure product quality and other relevant data. To support marketing approval, the data submitted must be sufficient in quality and quantity
20-F
2020 FY
ADCT
Adc Therapeutics SA
18 Mar 21
Annual report (foreign)
7:12am
and clinical trials are submitted to the FDA as part of a BLA, along with proposed labeling, chemistry and manufacturing information to ensure product … quality and other relevant data. To support marketing
approval, the data submitted must be sufficient in quality and quantity to establish
424B4
ADCT
Adc Therapeutics SA
25 Sep 20
Prospectus supplement with pricing info
4:14pm
information to ensure product quality and other relevant data. To support marketing approval, the data submitted must be sufficient in quality and quantity
F-1
ADCT
Adc Therapeutics SA
21 Sep 20
Registration statement (foreign)
4:30pm
as part of a BLA, along with proposed labeling, chemistry and manufacturing information to ensure product quality and other relevant data. To support
DRS
pwtryjn7z18y
11 Sep 20
Draft registration statement
12:00am
424B4
6b4frrm
18 May 20
Prospectus supplement with pricing info
8:52am
F-1/A
zx1 giamqkng
14 May 20
Registration statement (foreign) (amended)
6:08am
F-1/A
4cd0a57t ktdx
11 May 20
Registration statement (foreign) (amended)
6:26am
F-1
5ezgtf0
24 Apr 20
Registration statement (foreign)
5:23pm
DRS
ti1z7 b8l97ds4u
2 Mar 20
Draft registration statement
12:00am
F-1/A
75aktdr0fd
23 Sep 19
Registration statement (foreign) (amended)
6:08am
F-1
s71agjz6m kpyvbw
6 Sep 19
Registration statement (foreign)
5:12pm
DRS
lsss3
28 Jun 19
Draft registration statement
12:00am
- Prev
- 1
- Next